The Wall Street Journal: Pfizer says it won’t split into two separate companies

Pfizer Inc. said Monday that it would remain a single company, deciding not to split its established and new medical lines into separate companies.

For years, Pfizer PFE, +0.32% has considered the idea of splitting its business into newer, patent-protected pharmaceuticals and a separate company for older products.

In April Pfizer said it would make a decision on a potential split by the end of the year, after it and Allergan PLC AGN, +0.21% ended their planned $150 billion merger as the Obama administration took aim at the deal that would have moved the U.S. drug company to Ireland to lower its taxes.

>>> Original Source <<<